Samson Rock Capital LLP Dice Therapeutics, Inc. Transaction History

Samson Rock Capital LLP

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 08, 2022	SELL	$22.41 - $37.54 $164,332 - $275,280	-7,333 Closed	0 $0
Q3 2021 Oct 18, 2021	BUY	$31.92 - $37.0 $234,069 - $271,321	7,333 New	7,333 $240,000

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Samson Rock Capital LLP, based on Form 13F filings with the SEC.

Stay updated on Samson Rock Capital LLP with notifications on news.